855662-75-8

Upstream product

• 855662-73-6 (+)-(3R,5R)-1-fluoro-5-O-benzyloxy-3-(O-trityloxymethyl)cyclopent-1-ene 
• 341553-93-3 (3aR,4R,6S,6aS)-4-Benzyloxy-6-tert-butoxymethyl-2,2-dimethyl-tetrahydro-cyclopenta[1,3]dioxole 
• 341553-94-4 (-)-(1R,2S,3S,4R)-1-O-benzyloxy-2,3-dihydroxyl-4-hydroxymethylcyclopentane 
• 855662-72-5 (+)-(2R,4R)-1-difluoro-2-O-benzyloxy-4-(O-trityloxymethyl)cyclopentane 
• 855662-70-3 (+)-(1R,2S,4R)-1-O-benzyloxy-2-hydroxyl-4-(O-trityloxymethyl)cyclopentane 
• 855662-71-4 (+)-(2R,4R)-2-O-benzyloxy-4-(O-trityloxymethyl)cyclopentan-1-one 
• 855662-68-9 (+)-(1R,2S,4R)-1-O-benzyloxy-2-hydroxyl-4-hydroxymethylcyclopentane 
• 855662-67-8 (+)-(1R,2S,3S,4R)-1-O-benzyloxy-2,3-anhydro-4-hydroxymethylcyclopentane 

Downstream Products

• 855662-78-1 (+)-(3R,5R)-1-fluoro-3-(O-tert-butyldimethylsilyloxymethyl)-5-O-benzyloxycyclopent-1-ene 

Relevant academic research and scientific papers

Synthesis, antiviral activity, and mechanism of drug resistance of D- and L-2′,3′-didehydro-2′,3′-dideoxy-2′- fluorocarbocyclic nucleosides

Carbocyclic nucleosides have received much attention due to their interesting biological activity and metabolic stability. Among nucleoside analogues, a fluorine substitution on the carbohydrate moiety or introduction of a 2′,3′-unsaturated structure moti